Clik here to view.
Panel Rejects Eli Lilly Claim Over Canadian Patent Law, Orders Company to Pay...
In the early 1990s, Eli Lilly applied for patent protection in Canada for two chemical compounds, olanzapine and atomoxetine. The company had already obtained patents over the compounds, but asserted...
View ArticleClik here to view.
US continue to bully India – Place India again in Special 301 Priority Watch...
Yet again, USTR places India on its Priority Watch List in Special report 301 stating the lack of sufficient measurable improvements to its IP framework that negatively affects U.S. right holders...
View ArticleClik here to view.
June 2017 Alert: Pressure on countries hiked by US on IP
The US government is stepping up on TRIPS plus pressure through bilateral forums based on a US law that passed under Obama to strengthen IPR enforcement and the 301 process. Countries targeted include...
View ArticleClik here to view.
The Trump Executive Order on drug prices: not what was promised nor needed,...
Source: Medium Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six page document outlining the draft provisions or objectives of a proposed Presidential Executive Order (EO) on...
View ArticleClik here to view.
Section 301: US investigates allegations of forced technology transfers to China
Source: EastAsia Forum Authors: Zhiyao (Lucy) Lu and Gary Clyde Hufbauer, Peterson Institute for International Economics On 18 August 2017, the Trump administration invoked Section 301 of the Trade Act...
View ArticleThe scalpels are out ahead of ‘Special 301’ Report
by PT Jyothi Datta | The HinduBusinessLine Indian pharma pushes back against US trade body’s criticism of its IPR protection record For the past five years, a lone Indian pharmaceutical representation...
View ArticleUSTR Priority Watch List calls out countries for protecting public health
Source: MSF Access | April 27, 2018 NEW YORK, APRIL 27, 2018-The Office of the United States Trade Representative (USTR) released its annual “Special 301 Report” today, which reviews countries based on...
View ArticleWhy India may not be able to ignore USTR’s 2018 Special 301 report
Source : Business Line | May 1, 2018 The United States Trade Representative has, in its “2018 Special 301 Report”, placed India on the “priority watch list”, again. A move that has been labelled ‘anti...
View ArticleLIES, DISTORTIONS, AND FALSE PROMISE: THE U.S. POSITION ON COMPULSORY...
Source: infojustice.org | May 1, 2018 Every year since the late 1980s, the U.S. has published a Special 301 Watchlist targeting countries that U.S. intellectual property-based industries, like Big...
View Article‘Big Pharma’ backs Trump’s Asia trade squeeze
Source: ASIA TIMES | May 03, 2018 US President Donald Trump’s administration stands accused of deploying bullying tactics to promote greater market access for American pharmaceutical companies by...
View Article